A recent report from Deshpande et al. [33] suggests that p53 and miR-192 up-regulates each other's expression under diabetic conditions, and might play a role in the pathogenesis of diabetic nephropathy by inducing hypertrophy and fibrosis of glomerular mesangial cells. Here, TP53 is linked to diabetic kidney disease.